(Q38644824)

5 September 2017

Implications of Augmented Renal Clearance on Drug Dosing in Critically Ill Patients: A Focus on Antibiotics (English)

1 reference

5 September 2017

0 references

Athena L V Hobbs

1

1 reference

5 September 2017

Katherine M Shea

series ordinal

2

1 reference

5 September 2017

Kirsten M Roberts

series ordinal

3

1 reference

5 September 2017

Mitchell J Daley

series ordinal

4

1 reference

5 September 2017

language of work or name

English

0 references

publication date

1 November 2015

1 reference

5 September 2017

1 reference

5 September 2017

35

1 reference

5 September 2017

11

1 reference

5 September 2017

1063-1075

1 reference

Augmented renal clearance: implications for antibacterial dosing in the critically ill.

5 September 2017

1 reference

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

21 January 2018

1 reference

Physiological changes in the critically ill patient with sepsis

21 January 2018

1 reference

Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis

21 January 2018

1 reference

ARC--augmented renal clearance

21 January 2018

1 reference

Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy

21 January 2018

1 reference

Augmented renal clearance in critically ill patients: incidence, associated factors and effects on vancomycin treatment

21 January 2018

1 reference

Clinical implications of antibiotic pharmacokinetic principles in the critically ill.

21 January 2018

1 reference

Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: identifying at-risk patients

21 January 2018

1 reference

Norepinephrine and vital organ blood flow during experimental hyperdynamic sepsis

21 January 2018

1 reference

Augmented renal clearance in the ICU: results of a multicenter observational study of renal function in critically ill patients with normal plasma creatinine concentrations*.

21 January 2018

1 reference

High creatinine clearance in critically ill patients with community-acquired acute infectious meningitis.

21 January 2018

1 reference

Augmented renal clearance in the critically ill: how to assess kidney function.

21 January 2018

1 reference

Pharmacokinetic-pharmacodynamic considerations in the design of hospital-acquired or ventilator-associated bacterial pneumonia studies: look before you leap!

21 January 2018

1 reference

Augmented creatinine clearance in traumatic brain injury

21 January 2018

1 reference

Augmented Renal Clearance in Patients with Subarachnoid Hemorrhage.

21 January 2018

1 reference

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

Low baseline serum creatinine concentration predicts mortality in critically ill patients independent of body mass index

21 January 2018

1 reference

Cefepime versus cefpirome: the importance of creatinine clearance

21 January 2018

1 reference

Accuracy of short-duration creatinine clearance determinations in predicting 24-hour creatinine clearance in critically ill and injured patients

21 January 2018

1 reference

Modified Augmented Renal Clearance score predicts rapid piperacillin and tazobactam clearance in critically ill surgery and trauma patients

21 January 2018

1 reference

Plasma and target-site subcutaneous tissue population pharmacokinetics and dosing simulations of cefazolin in post-trauma critically ill patients

21 January 2018

1 reference

Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?

21 January 2018

1 reference

Augmented renal clearance, low β-lactam concentrations and clinical outcomes in the critically ill: an observational prospective cohort study

21 January 2018

1 reference

Identification of optimal renal dosage adjustments for high-dose extended-infusion cefepime dosing regimens in hospitalized patients.

21 January 2018

1 reference

Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia.

21 January 2018

1 reference

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

21 January 2018

1 reference

Augmented renal clearance in septic patients and implications for vancomycin optimisation.

21 January 2018

1 reference

Influence of glomerular filtration rate on the clearance of vancomycin administered by continuous infusion in burn patients

21 January 2018

1 reference

High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures.

21 January 2018

1 reference

Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients.

21 January 2018

1 reference

Simulation of antibiotic pharmacodynamic exposure for the empiric treatment of nosocomial bloodstream infections: a report from the OPTAMA program

21 January 2018

1 reference

Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial

21 January 2018

1 reference

Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams

21 January 2018

1 reference

Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability

21 January 2018

1 reference

In vivo pharmacodynamic activity of daptomycin

21 January 2018

1 reference

Variability of pharmacokinetic parameters in patients receiving different dosages of daptomycin: is therapeutic drug monitoring necessary?

21 January 2018

1 reference

Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

Experience with a once-daily aminoglycoside program administered to 2,184 adult patients

21 January 2018

1 reference

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

21 January 2018

1 reference

Levofloxacin pharmacokinetics and pharmacodynamics in patients with severe burn injury.

21 January 2018

1 reference

The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach

21 January 2018

1 reference

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.

21 January 2018

1 reference

Steady-state pharmacokinetics of intravenous levetiracetam in neurocritical care patients

21 January 2018

1 reference

Augmented renal clearance of vancomycin and levetiracetam in a traumatic brain injury patient

21 January 2018

1 reference

DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PHAR.1653

1 reference

5 September 2017

1 reference